[Fetal DNA in maternal blood]

Area of Science:

• Molecular Biology
• Genetics
• Obstetrics

Context:

• Fetal cells and cell-free fetal DNA (cffDNA) are present in maternal circulation.
• Traditional prenatal diagnosis often involves invasive procedures with associated risks.
• Advances in real-time polymerase chain reaction (PCR) enable sensitive detection and quantification of fetal DNA in maternal blood.

Purpose:

• To evaluate the utility of non-invasive fetal DNA analysis from maternal blood for prenatal diagnosis.
• To assess the accuracy of fetal sex determination using Y-chromosome PCR.
• To determine the efficacy of non-invasive RhD genotyping in RhD-negative women.

Summary:

• Real-time PCR techniques allow for the identification and quantification of fetal DNA in maternal blood.
• Fetal sex determination via Y-chromosome PCR demonstrates 100% specificity and high sensitivity, increasing with gestational age, potentially reducing invasive prenatal diagnosis for X-linked diseases by 50%.
• Non-invasive fetal RhD genotyping shows 100% sensitivity and specificity, rendering anti-D immunoprophylaxis unnecessary for RhD-negative mothers with RhD-negative fetuses.

Impact:

• Enables early, non-invasive fetal sexing to guide management of conditions like congenital adrenal hyperplasia, reducing maternal dexamethasone use.
• Minimizes the need for invasive prenatal diagnostic procedures, thereby reducing risks to the fetus and mother.
• Paves the way for detecting a wider range of inherited disorders non-invasively from maternal plasma, with ongoing research into conditions like preterm labor, pre-eclampsia, and aneuploidy.